Das Evangelische Krankenhaus Düsseldorf ist ein Akutkrankenhaus mit zehn Fachabteilungen und insgesamt 513 Betten. Es wird von der Stiftung Evangelisches Krankenhaus Düsseldorf getragen.

During the past decade, Evangelisches Krankenhaus conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 5 clinical trials were completed, i.e. on average, 23.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evangelisches Krankenhaus" #1 sponsor was "Biotronik SE & Co. KG" with 5 trials, followed by "AGO Study Group" with 4 trials sponsored, "Evangelisches Krankenhaus Düsseldorf" with 4 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored and "Medtronic - MITG" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelisches Krankenhaus" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Nordic Society of Gynaecological Oncology - Clinical Trials Unit" with 2 trials as a collaborator, "Olympus" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Evangelisches Krankenhaus" are "Ovarian Cancer" (8 trials), "Atrial Fibrillation" (6 trials), "Fallopian Tube Cancer" (4 trials), "Heart Failure" (4 trials) and "Colonic Diseases" (3 trials). Many other conditions were trialed in "Evangelisches Krankenhaus" in a lesser frequency.

Most popular intervention types in "Evangelisches Krankenhaus" are "Device" (20 trials), "Drug" (10 trials), "Procedure" (10 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (3 trials), "Placebo" (2 trials), "paclitaxel" (2 trials), "ARCHIMEDES Biodegradable Biliary and Pancreatic Stent" (1 trials) and "Abagovomab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Evangelisches Krankenhaus" are 38 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Evangelisches Krankenhaus". 3 are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Evangelisches Krankenhaus, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Evangelisches Krankenhaus, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".